HER2 (ERBB2), a known proto-oncogene, is located at the long arm of human chromosome 17 whose overexpression, and hence their receptors, is present in about 20–30% of breast cancers as a result of amplification of the chromosomal region 17q12-211. This evidence concerns the gene ERBB2 and breast carcinoma.